FDA 483 - Paragon Swiss - January 12, 2024
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Paragon Swiss in Santa Clara, CA, was inspected from January 8-12, 2024, and received a Form FDA 483 with three observations. The inspection revealed significant deficiencies in the firm's quality control unit, including a lack of quality agreements and inadequate procedures for documentation and supplier qualification. Additionally, the firm's employee training program was found to be deficient, and there were issues with stability testing and release testing for active pharmaceutical ingredients and starting materials.
ID · c4723d5d-745d-45a5-ab58-24d5e344388c